Home
|
My Account
Home
About SignaGen
About Us
SignaGen Blog
Technologies
Support
Protocols
Troubleshooting Tips
Transfection Tips
Product Service Citations
Contact Us
Contact Info
Employment
Distributors
How to Order
My Account
Log In
Create Account
Shopping Cart
0 item(s) in cart
Specials
|
Featured Items
|
View All Products
Viral Vector Production
> Adenovirus Production Service
> Pre-made Adenovirus
> shRNA/miRNA Adenovirus Svc
> Ready-to-package Adenovirus
> AAV Production Service
> Pre-made AAVs
> shRNA/miRNA AAV Service
> Lentivirus Production Service
> Pre-made Lentivirus
Transfection Reagents
>
In Vitro
DNA Transfection Reagents
>
In Vitro
siRNA Transfection Reagents
>
In Vivo
Transfection Reagents
> Pre-optimized Transfection Reagents->
> Transfection Accessories
Specials ...
New Products ...
Featured Products ...
All Products ...
Featured Items [more]
Custom Adenovirus Production Full Service, Medium Scale
Technical Resources
Introduction of AAV
Introduction of Adenovirus
AAV FAQs
Adenovirus FAQs
Product & Service Citations
Virus Comparison Table
Home
::
> shRNA/miRNA AAV Service
:: shRNA/miRNA rAAV Packaging, Medium Scale
> shRNA/miRNA AAV Service
Product 2/6
shRNA/miRNA rAAV Packaging, Medium Scale
Catalog #: SL100873
Unit Size: 0.2 mL (>10
13
VG/mL)
shRNA/miRNA AAV Packaging in Medium Scale
Features:
- Excellent gene delivery efficiency in most cell types including dividing and non-dividing or primary cells.
- Multiple serotypes
(AAV-1, AAV-2, AAV-3, AAV-4, AAV-5, AAV-6, AAV-8, AAV-9, AAV-DJ/8 and AAV-DJ)
.
- Persistent transgene expression.
- Induce efficient gene silencing.
Service Description:
- Medium scale co-transfection of
AAV·HT™ 293 cells into
1xcell stack
.
- Harvest rAAV followed by purification via column filtration and
2xCsCl ultra-centrifugation.
- Titration via qPCR (measuring genome copies).
rAAV Serotypes We Offer:
AAV-1, AAV-2, AAV-3, AAV-4, AAV-5, AAV-6, AAV-7, AAV-8, AAV-9, AAV-PHP.B, AAV-PHP.eB, AAV-DJ/8 and AAV-DJ
.
Required Materials:
AAV cis plasmid carrying your shRNA or pre-miRNA, >150
µ
g.
Turnaround Time:
1
~ 2 weeks.
Deliverables:
>0.2 mL of super purified in vivo grade rAAV vector at >1E+13 VG/mL*.
We offer discount for new customer, please
request a quote
with us today.
We also offer truncated custom shRNA AAV service, please
request a quote
with us today.
Figure 1. A comparison of purity and infectivity of rAAV vectors from different sources showing super purified and super infectious (close to clinical trial grade) rAAV vector prepared via our advanced double CsCl ultra-centrifugation approach.
A. rAAV vectors (total 1E+9 VG per lane) from different sources were resolved on SDS-PAGE followed by silver staining. Lane 1: GMP manufactured rAAV vector from CHOP; Lane 2: rAAV prepared via our advanced 2xCsCl ultra-centrifugation approach; Lane 3: rAAV from Vector Core of BCM; Lane 4: rAAV from our competitor "V"; Lane 5: rAAV from our competitor "C"; Lane 6: Protein marker.
B. Super infectious rAAV vector prepared via advanced
double CsCl ultra-centrifugation
. Left panel: rAAV9-GFP (total 5E+9 VG) from our competitor "V" injected to mouse eye; Right panel: rAAV-9-GFP (total 5E+9 VG) purified via advanced 2xCsCl
ultra-centrifugation
injected to mouse eye.
Figure 2. A comparison of infectivity of rAAV vectors from different sources showing super purified rAAV prepared via advanced double CsCl ultra-centrifugation approach is super infectious.
rAAV1-GFP (total 2E+9 VG) from different sources were injected to mouse muscle tissue. The GFP fluorescence was visualized 3 weeks post injection. A. rAAV1-GFP from our competitor "V"; B. rAAV1-GFP from our pre-made rAAVs stock purified via advanced
double CsCl ultra-centrifugation. C.
Quantification data showed that our super purified rAAV (bar 2) is ~ 9 times more infectious than that (bar 1) prepared via conventional CsCl ultra-centrifugation.
* Final viral yield may depend on the nature of transgene.
Home
::
Privacy Policy
::
Terms & Conditions
::
Contact Us
Copyright © 2024
SignaGen Laboratories
. All Rights Reserved.